top of page

Clinical Need

Loïc first observed the shortcomings of current pVADs while attending a medical conference. He watched a challenging live case where the physicians were unable to deliver a percutaneous ventricular assist device (pVAD) through an axillary (shoulder) artery access site. Ultimately, the physician took a different treatment approach while also having to deal with closure of the axillary artery large bore access site in the middle of the procedure.

​

We are creating a pVAD with the smallest delivery profile  on the market. This will allow our blood pump to protect the lives of thousands of people every year who are ineligible for treatment with the current pVADs due to blood vessel size or blood vessel disease.

Our story

light bulb giving off red blood cells.jpg
Early Prototype Rendering 2.JPG
A narwhal laying on top of a dollar sign.jpg

Q1 2022

Foundation of

Narwhal Medical

a nerdy sheep studying a science book.jpg

Q2 2022

Initial prototypes created demonstrating concept potential

Q3 2022

Major strategic partner joins Narwhal Medical to create functional

proof-of-concept prototypes

Granted U.S.jpg

Q2 2023

First fully functional prototype successfully delivered and operated in an animal

implanted2.JPG

Q3-Q4 2023

First 2 U.S. patents were issued

a wealthy narwhal with a treasure chest.jpg

Q1 2024

- Prototype flow rate doubled

- Delivery profile decreased by 40%

- Second successful animal study completed

Q3 2024

-Closed a fully subscribed seed round

-2 additional U.S. patents were issued

an elephant family squished into a small car trying to take a road trip.jpg

Clinical Un-met Need

Loïc first observed the shortcomings of current pVADs while attending a medical conference. He watched a challenging live case where the physicians were unable to deliver a pVAD through an axillary (shoulder) artery access site. Ultimately, the physician took a different treatment approach while also having to deal with closure of the axillary artery large bore access site in the middle of the procedure.

​

We are creating the smallest delivery profile blood pump on the market. This will allow our blood pump to protect the lives of thousands of people every year who are ineligible for treatment with the current percutaneous blood pump technologies due to blood vessel size or blood vessel disease.

Q1 2022

Narwhal Medical Was Founded

Loïc put his mind to addressing the clinically un-met need for a miniaturized percutaneous blood pump. An innovative solution was conceptualized and Narwhal Medical was founded.

light bulb giving off red blood cells.jpg
Early Prototype Rendering 2.JPG

Q2 2022

Prototyping Progress

Initial prototypes created demonstrating the concept potential.

Q3 2022

Initial Funding Secured

Narwhal Medical signed a contract with a major strategic partner to create functional proof of concept prototypes.

A narwhal laying on top of a dollar sign.jpg
a nerdy sheep studying a science book.jpg

Q2 2023

First animal study

First fully functional prototype was successfully delivered and operated in an animal.

Q3-Q4 2023

Patents

First 2 U.S. patents were issued.

Granted U.S.jpg
implanted2.JPG

Q1 2024

Prototyping Progress

- Prototype flow rate doubled

- Delivery profile decreased by 40%

- Second successful animal study conducted

Q3 2024

Seed Funding

Closed a fully subscribed seed round.

Patents

2 additional U.S. patents were issued.

a wealthy narwhal with a treasure chest.jpg
A plain background with a crystal ball with an anatomical human heart inside.jpg

Q4 2024

Stay Tuned For More Exciting Developments

Procedural Background

The blood vessels of the heart

Often when someone experiences a heart attack or chronic chest pain it is due to a blockage of one or more arteries in their heart. Many patients will undergo a procedure called a "percutaneous coronary intervention", or PCI for short, to open up the blockages. A physician will treat the affected arteries by accessing the arterial system through the patient's leg, collar bone area, or even their arm, carefully inserting a catheter and navigating it until it reaches the affected area.​

Due to several factors including severity of illness, condition of the heart, and age, some patients might be at risk for their heart not being able to pump enough blood during a PCI procedure. Catheterbased blood pumps have been shown to be effective for such patients during a PCI procedure by providing pumping assistance to the heart and therefore allowing the heart to not work as hard.

 

A catheter-based blood pump is commonly referred to as a

"Percutaneous Ventricular Assist Device" or pVAD.

​

Many patients are not eligible for a pVAD due to their size limitations. Our small, ultra deliverable blood pump will allow more patients to receive the critical care they need.

bottom of page